CNS penetration of potential anti-COVID-19 drugs

J Neurol. 2020 Jul;267(7):1880-1882. doi: 10.1007/s00415-020-09866-5. Epub 2020 May 2.
No abstract available

Publication types

  • Letter
  • Review

MeSH terms

  • Animals
  • Azetidines / metabolism
  • Azetidines / pharmacology
  • Azetidines / therapeutic use
  • Betacoronavirus*
  • Blood-Brain Barrier / drug effects
  • Blood-Brain Barrier / metabolism
  • Brain / drug effects
  • Brain / metabolism*
  • COVID-19
  • Central Nervous System / drug effects
  • Central Nervous System / metabolism
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / metabolism*
  • Humans
  • Hydroxychloroquine / metabolism
  • Hydroxychloroquine / pharmacology
  • Hydroxychloroquine / therapeutic use
  • Pandemics
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / metabolism*
  • SARS-CoV-2
  • Sulfonamides / metabolism
  • Sulfonamides / pharmacology
  • Sulfonamides / therapeutic use

Substances

  • Azetidines
  • Sulfonamides
  • Hydroxychloroquine
  • baricitinib